Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
Molecular Cancer Therapeutics
|
March 24, 2012
Evading Pgp activity in drug-resistant cancer cells: a structural and functional study of antitubulin furan metotica compounds
Tam Luong Nguyen, Maria Rosaria Cera, Andrea Pinto, et al.
The Journal of Biological Chemistry
|
August 10, 2005
Anthrax biosensor, protective antigen ion channel asymmetric blockade
Kelly M Halverson, Rekha G Panchal, Tam L Nguyen, et al.
Molecular Cancer Therapeutics
|
July 26, 2019
Specific RITA Modification Produces Hyperselective Cytotoxicity While Maintaining <i>In Vivo</i> Antitumor Efficacy
Brian D Peyser, Ann Hermone, Joseph M Salamoun, et al.
ACS Medicinal Chemistry Letters
|
December 1, 2010
Pharmacophore Refinement Guides the Rational Design of Nanomolar-Range Inhibitors of the Botulinum Neurotoxin Serotype A Metalloprotease
Jonathan E Nuss, Yuxiang Dong, Laura M Wanner, et al.
Chembiochem : a European Journal of Chemical Biology
|
February 8, 2005
Structure-aided optimization of kinase inhibitors derived from alsterpaullone
Conrad Kunick, Zhihong Zeng, Rick Gussio, et al.
European Journal of Medicinal Chemistry
|
April 21, 2012
The synthesis of 2,5-bis(4-amidinophenyl)thiophene derivatives providing submicromolar-range inhibition of the botulinum neurotoxin serotype A metalloprotease
Igor Opsenica, Vuk Filipovic, Jon E Nuss, et al.
Bioorganic & Medicinal Chemistry
|
May 26, 2006
Homology model of RSK2 N-terminal kinase domain, structure-based identification of novel RSK2 inhibitors, and preliminary common pharmacophore
Tam Luong Nguyen, Rick Gussio, Jeffrey A Smith, et al.
Journal of Chemical and Pharmaceutical Research
|
October 1, 2011
RSK2 Binding Models Delineate Key Features for Activity
Rick Gussio, Michael J Currens, Dominic A Scudiero, et al.
Plos One
|
July 9, 2010
Iterative structure-based peptide-like inhibitor design against the botulinum neurotoxin serotype A
Jorge E Zuniga, Jared T Hammill, Omri Drory, et al.
Journal of Medicinal Chemistry
|
September 16, 2005
A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach
Tam Luong Nguyen, Connor McGrath, Ann R Hermone, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
Molecular Cancer Therapeutics
|
March 24, 2012
Evading Pgp activity in drug-resistant cancer cells: a structural and functional study of antitubulin furan metotica compounds
Tam Luong Nguyen, Maria Rosaria Cera, Andrea Pinto, et al.
The Journal of Biological Chemistry
|
August 10, 2005
Anthrax biosensor, protective antigen ion channel asymmetric blockade
Kelly M Halverson, Rekha G Panchal, Tam L Nguyen, et al.
Molecular Cancer Therapeutics
|
July 26, 2019
Specific RITA Modification Produces Hyperselective Cytotoxicity While Maintaining <i>In Vivo</i> Antitumor Efficacy
Brian D Peyser, Ann Hermone, Joseph M Salamoun, et al.
ACS Medicinal Chemistry Letters
|
December 1, 2010
Pharmacophore Refinement Guides the Rational Design of Nanomolar-Range Inhibitors of the Botulinum Neurotoxin Serotype A Metalloprotease
Jonathan E Nuss, Yuxiang Dong, Laura M Wanner, et al.
Chembiochem : a European Journal of Chemical Biology
|
February 8, 2005
Structure-aided optimization of kinase inhibitors derived from alsterpaullone
Conrad Kunick, Zhihong Zeng, Rick Gussio, et al.
European Journal of Medicinal Chemistry
|
April 21, 2012
The synthesis of 2,5-bis(4-amidinophenyl)thiophene derivatives providing submicromolar-range inhibition of the botulinum neurotoxin serotype A metalloprotease
Igor Opsenica, Vuk Filipovic, Jon E Nuss, et al.
Bioorganic & Medicinal Chemistry
|
May 26, 2006
Homology model of RSK2 N-terminal kinase domain, structure-based identification of novel RSK2 inhibitors, and preliminary common pharmacophore
Tam Luong Nguyen, Rick Gussio, Jeffrey A Smith, et al.
Journal of Chemical and Pharmaceutical Research
|
October 1, 2011
RSK2 Binding Models Delineate Key Features for Activity
Rick Gussio, Michael J Currens, Dominic A Scudiero, et al.
Plos One
|
July 9, 2010
Iterative structure-based peptide-like inhibitor design against the botulinum neurotoxin serotype A
Jorge E Zuniga, Jared T Hammill, Omri Drory, et al.
Journal of Medicinal Chemistry
|
September 16, 2005
A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach
Tam Luong Nguyen, Connor McGrath, Ann R Hermone, et al.
Page
of 5